SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-02-000002
Filing Date
2002-03-19
Accepted
2002-03-19 00:00:00
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 LIGAND 2001 FORM 10K ligand200110k.htm 10-K 405896
3 EX 10.240 ex10-240.txt EX-10 28661
4 EX 10.242 ex10-241.txt EX-10 23749
5 EX 10.242 ex10-242.txt EX-10 14136
6 EX 21.1 SUBSIDIARIES ex21-1.txt EX-21 1066
7 D&T CONSENT ex23-1.txt EX-23 649
8 E&Y CONSENT ex23-2.txt EX-23 785
  Complete submission text file 0000886163-02-000002.txt   477068
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20720 | Film No.: 02578943
SIC: 2834 Pharmaceutical Preparations